These results, together with the inhibition of focal adhesion turnover and tumour progression in mice by SKF96365, a SOC inhibitor, suggested that SOCE underlies a significant part of the Ca2+ entry required for cell migration. The gene discussed is UBXN11; the disease is neoplasm.